338 related articles for article (PubMed ID: 26637732)
41. Allogeneic hematopoietic stem cell transplantation for the treatment of BCR-ABL1-negative atypical chronic myeloid leukemia and chronic neutrophil leukemia: A retrospective nationwide study in Japan.
Itonaga H; Ota S; Ikeda T; Taji H; Amano I; Hasegawa Y; Ichinohe T; Fukuda T; Atsuta Y; Tanizawa A; Kondo T; Miyazaki Y
Leuk Res; 2018 Dec; 75():50-57. PubMed ID: 30458320
[TBL] [Abstract][Full Text] [Related]
42. [Chronic neutrophilic leukemia complicated with multiple myeloma: two cases report and literature review].
Jiang B; Qi JY; Li QH; Xu Y; Sun MY; Zheng WW; Chen F; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):688-91. PubMed ID: 27587251
[TBL] [Abstract][Full Text] [Related]
43. CSF3R-, ASXL1-, and SETBP1-mutated chronic neutrophilic leukemia with monoclonal gammopathy of undetermined significance in a patient who developed severe ascites due to sinusoidal neutrophilic infiltration.
Harada N; Mukai D; Izuta Y; Shibano I; Kizawa Y; Shiragami H; Ohnishi N; Hosaka N; Mugitani A
Pathol Int; 2024 Feb; 74(2):93-95. PubMed ID: 38050833
[No Abstract] [Full Text] [Related]
44. Chronic neutrophilic leukemia complicated with monoclonal gammopathy of undetermined significance: A case report and literature review.
Gao JP; Zhai LJ; Gao XH; Min FL
J Clin Lab Anal; 2022 Apr; 36(4):e24287. PubMed ID: 35170077
[TBL] [Abstract][Full Text] [Related]
45. [The clinical characteristics, gene mutations and prognosis of chronic neutrophilic leukemia].
Cui YJ; Jiang Q; Liu JQ; Li B; Xu ZF; Qin TJ; Zhang Y; Cai WY; Zhang HL; Fang LW; Pan LJ; Hu NB; Qu SQ; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2017 Jan; 38(1):28-32. PubMed ID: 28219221
[No Abstract] [Full Text] [Related]
46. Genetically informed therapy in leukemia.
Radich J
N Engl J Med; 2013 May; 368(19):1838-9. PubMed ID: 23656651
[No Abstract] [Full Text] [Related]
47. Chronic neutrophilic leukemia 2014: Update on diagnosis, molecular genetics, and management.
Elliott MA; Tefferi A
Am J Hematol; 2014 Jun; 89(6):651-8. PubMed ID: 24845374
[TBL] [Abstract][Full Text] [Related]
48. De novo CSF3R mutation associated with transformation of myeloproliferative neoplasm to atypical CML.
Bartels S; Lehmann U; Büsche G; Schlue J; Hussein K; Debatin D; Karcher A; Andrulis M; Schirmacher P; Kreipe H
Ann Hematol; 2015 Jul; 94(7):1255-6. PubMed ID: 25865944
[No Abstract] [Full Text] [Related]
49. Atypical Chronic Myeloid Leukemia: Where Are We Now?
Crisà E; Nicolosi M; Ferri V; Favini C; Gaidano G; Patriarca A
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962122
[TBL] [Abstract][Full Text] [Related]
50. Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms.
Wang SA; Hasserjian RP; Fox PS; Rogers HJ; Geyer JT; Chabot-Richards D; Weinzierl E; Hatem J; Jaso J; Kanagal-Shamanna R; Stingo FC; Patel KP; Mehrotra M; Bueso-Ramos C; Young KH; Dinardo CD; Verstovsek S; Tiu RV; Bagg A; Hsi ED; Arber DA; Foucar K; Luthra R; Orazi A
Blood; 2014 Apr; 123(17):2645-51. PubMed ID: 24627528
[TBL] [Abstract][Full Text] [Related]
51. Chronic neutrophilic leukemia: a clinical perspective.
Menezes J; Cigudosa JC
Onco Targets Ther; 2015; 8():2383-90. PubMed ID: 26366092
[TBL] [Abstract][Full Text] [Related]
52. Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management.
Szuber N; Elliott M; Tefferi A
Am J Hematol; 2020 Feb; 95(2):212-224. PubMed ID: 31769070
[TBL] [Abstract][Full Text] [Related]
53. Atypical CML with mutated SRSF2, ASXL1, CSF3R, and MPL.
Tran A; Wong M
Blood; 2021 Dec; 138(26):2890. PubMed ID: 34967865
[No Abstract] [Full Text] [Related]
54. Chronic neutrophilic leukemia: new science and new diagnostic criteria.
Szuber N; Tefferi A
Blood Cancer J; 2018 Feb; 8(2):19. PubMed ID: 29440636
[TBL] [Abstract][Full Text] [Related]
55. Clonal evolution in a chronic neutrophilic leukemia patient.
Zhang QG; Wang J; Gong WY; Jing QC
Hematology; 2019 Dec; 24(1):455-458. PubMed ID: 31076019
[TBL] [Abstract][Full Text] [Related]
56. Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis.
Shou LH; Cao D; Dong XH; Fang Q; Wu Y; Zhang Y; Fei JP; Xu BL
PLoS One; 2017; 12(2):e0171608. PubMed ID: 28158286
[TBL] [Abstract][Full Text] [Related]
57. Durable Disease Control with MEK Inhibition in a Patient with NRAS-mutated Atypical Chronic Myeloid Leukemia.
Khanna V; Pierce ST; Dao KH; Tognon CE; Hunt DE; Junio B; Tyner JW; Druker BJ
Cureus; 2015 Dec; 7(12):e414. PubMed ID: 26870618
[TBL] [Abstract][Full Text] [Related]
58. Chronic neutrophilic leukemia (CNL) with karyotypic abnormalities associated with plasma cell dyscrasia: a case report.
Masini L; Salvarani C; Macchioni P; Baldi G; Rossi F; Croci G; Prandi S; Davoli C; Portioli I; Gobbi F
Haematologica; 1992; 77(3):277-9. PubMed ID: 1427435
[TBL] [Abstract][Full Text] [Related]
59. [New mutations in myeloproliferative neoplasms; 2014 update].
Kirito K
Rinsho Ketsueki; 2014 Oct; 55(10):1833-40. PubMed ID: 25297747
[No Abstract] [Full Text] [Related]
60. Chronic neutrophilic leukemia: 2018 update on diagnosis, molecular genetics and management.
Elliott MA; Tefferi A
Am J Hematol; 2018 Aug; 93(4):578-587. PubMed ID: 29512199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
